Clinical trial · Interventional
Healthcare Provider Human Papillomavirus Education and Professional Skills Intervention
Implementing Innovative and Strategic Approaches to Prevent and Mitigate the Deleterious Effects of HPV Across the Lifespan of Hispanics of Mexican Origin: Healthcare Provider Intervention
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Healthcare providers (HCP) serving the El Paso U.S.-Mexico Border Region will be recruited to compare educational and professional skills interventions focused on the human papillomavirus (HPV). Our hypothesis is that improving provider knowledge and communication strategies about HPV and its vaccine will reduce hesitancy and increase uptake and completion among the populations they serve.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Health Knowledge, Attitudes, Practice | — | UNRESOLVED | — |
| Health Personnel Attitude | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| General HPV Education and Communication Skills Control Group | Behavioral | — | UNRESOLVED |
| Tailored HPV Education and Professional Skills Intervention Group | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Treatment
- description
- A tailored HPV education and professional skills intervention.
- interventionNames
- Behavioral: Tailored HPV Education and Professional Skills Intervention Group
- type
- ACTIVE_COMPARATOR
- label
- Control
- description
- General/publicly available educational materials on HPV and communication skills.
- interventionNames
- Behavioral: General HPV Education and Communication Skills Control Group
Primary outcomes (3)
- measure
- Healthcare Provider (HCP) Practices Scale Score
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Current (in practice) or emerging (in training - medical student, resident, or fellow) healthcare provider * Working/training or living in the El Paso U.S.-Mexico Border Region (i.e., El Paso County, TX-Southern New Mexico) * Have the authorization to recommend/prescribe/administer the HPV vaccine Exclusion Criteria: * Unaffiliated with the El Paso U.S.-Mexico Border Region (i.e., El Paso County, TX-Southern New Mexico) * Participation in Phases I or II of the larger research project \[cross-sectional phases\] * Does not identify as a current or emerging healthcare provider * Declines or is unable to participate in the full intervention and follow-up time-points * Unable to complete participation and activities in the English language
References
Publications (4)
- BACKGROUNDBrabin L, Roberts SA, Farzaneh F, Kitchener HC. Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. Vaccine. 2006 Apr 12;24(16):3087-94. doi: 10.1016/j.vaccine.2006.01.048. Epub 2006 Feb 9. PMID 16500736
- BACKGROUNDMcRee AL, Brewer NT, Reiter PL, Gottlieb SL, Smith JS. The Carolina HPV immunization attitudes and beliefs scale (CHIAS): scale development and associations with intentions to vaccinate. Sex Transm Dis. 2010 Apr;37(4):234-9. doi: 10.1097/OLQ.0b013e3181c37e15. PMID 19940807
- BACKGROUNDKatz ML, Krieger JL, Roberto AJ. Human papillomavirus (HPV): college male's knowledge, perceived risk, sources of information, vaccine barriers and communication. J Mens Health. 2011 Oct 1;8(3):175-184. doi: 10.1016/j.jomh.2011.04.002. PMID 21966351
- DERIVEDMartinez J, Cordero JI, Whitney M, LaRoche KL, Frietze G, Moya EM, Gosselink K. Web-Based Human Papillomavirus Education and Professional Skills Intervention for Health Care Providers: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2025 Apr 3;14:e60790. doi: 10.2196/60790. PMID 40179382